Cue Biopharma Stock Forecast

Buy candidate since Jun 17, 2026 Gain 0.64%

The Cue Biopharma Inc. stock price fell by -12.46% on the last day (Tuesday, 23rd Jun 2026) from $30.73 to $26.90. During the last trading day the stock fluctuated 18.45% from a day low at $25.80 to a day high of $30.56. The price has been going up and down for this period, and there has been a -7.5% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -28 thousand shares and in total, 93 thousand shares were bought and sold for approximately $2.49 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $24.54 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 89.58% during the next 3 months and, with a 90% probability hold a price between $46.53 and $88.69 at the end of this 3-month period.

CUE Signals & Forecast

The Cue Biopharma Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.72 and $26.77. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 07, 2026, and so far it has fallen -24.71%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cue Biopharma Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $25.49 and $23.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cue Biopharma Inc. finds support just below today's level at $25.49. If this is broken, then the next support from accumulated volume will be at $23.01 and $21.73.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $4.76 between high and low, or 18.45%. For the last week, the stock has had daily average volatility of 15.18%.

Our recommended stop-loss: $25.27 (-6.06%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 31 days ago.)

Trading Expectations (CUE) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Cue Biopharma Inc. to open at $27.75, and during the day (based on 14 day Average True Range), to move between $24.89 and $28.91, which gives a possible trading interval of +/-$4.02 (+/-16.16%) up or down from last closing price. If Cue Biopharma Inc. takes out the full calculated possible swing range there will be an estimated 16.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $25.49 (5.25%) than the resistance at $29.85 (10.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cue Biopharma Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cue Biopharma Inc. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.301 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $27.75 ( 3.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk